The researchers used genetic data from nearly 30,000 people, the release said. They found polygenic risk scores, built with data from multiple populations in Mount Sinai’s BioMe Biobank boosted IBD predictions for every population in the biobank.
Risk scores significantly improved predictions among Europeans, Ashkenazi Jewish and Hispanic ancestry in BioMe, the release said.
“The ability to accurately predict genetic disease risk in individuals across ancestries is a critical avenue that may positively affect patient outcomes, as early interventions and even preventive measures are being considered and developed,” said Judy Cho, MD, senior study author, in the release. “These findings support a need for greater genetic diversity, including more data on African American populations, to enhance disease risk predictions and reduce health disparities for all populations.”
Read more details here.
More articles on surgery centers:
Ohio health system acquires surgery center for $21M
2 Texas health systems suspend surgeries, others don’t
Stryker’s ASC-focused business: 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
